<DOC>
	<DOCNO>NCT02460042</DOCNO>
	<brief_summary>The aim study assess safety efficacy paclitaxel-releasing balloon catheter SeQuent® Please OTW treat de novo restenotic lesion peripheral artery . It intention trial treat suitable target lesion drug coat balloon ( DCB ) .</brief_summary>
	<brief_title>Clinical Post Market Clinical Follow-up ( PMCF ) Peripheral Arteries Treated With SeQuent® Please Over The Wire ( OTW )</brief_title>
	<detailed_description>This study non-randomized , prospective , multi-center , non-interventional study ( NIS=registry , Germany : §23b MPG )</detailed_description>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Inclusion Criteria ( patient ) : Willingness treat target lesion accord DCB concept Patients Rutherford class 2 5 Patients eligible peripheral revascularization mean Percutaneous Transluminal Angioplasty ( PTA ) Patients must 18 year age Patients mentally linguistically able understand aim study show sufficient compliance follow study protocol Patients must agree undergo least 12month clinical followup Patient able verbally acknowledge understand associate risk , benefit , treatment alternative therapeutic option trial , e.g . balloon angioplasty mean paclitaxeleluting PTAballoon catheter suitable device . Patients , provide informed consent , agree risk benefit state patient inform consent document . Inclusion Criteria ( lesion ) : Peripheral lesion peripheral artery knee reference vessel diameter 1.5 8.0 mm , lesion length ≥ 2 cm ≤ 27 cm angiographically documented* Diameter stenosis preprocedure must 70 % Target lesion knee Vessels must adequate runoff least one vessel foot . *Lesions separate less 2 cm consider one lesion Exclusion Criteria ( comer ) : Patient suitable revascularization interventional mean</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>